Skip to Main Content

Paper Details

Genomic Determinants of Homologous Recombination Deficiency across Human Cancers.
Cancers (Basel)
3
2021
ATM, ATR, ATR mutations, BRCA1 variants, BRCA1/2, Cancers, HRD, Homologous Recombination Deficiency, Human, PALB2, PARPi, TP53, TP53 mutations, breast cancer, cancer, cancer types, candidate genes, germline, ovarian, breast, pancreatic, stomach, bladder, and lung cancer, pathogenic germline variants, poly-ADP ribose, poly-ADP ribose polymerase, prostate cancers, tumor, tumors
Author NameAffiliation
Li DingMcDonnell Genome Institute, Washington University in St. Louis
Li DingSiteman Cancer Center, Washington University in St. Louis
Li DingMcDonnell Genome Institute, Washington University in St. Louis
Li DingSiteman Cancer Center, Washington University in St. Louis
Lajos PusztaiYale University
  • 1 - 5

Datasets

Release 1.2